Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, Vaccination site pain
Clinical narrative: dose number = 3; Sever soreness of at the site of injection; high fever (cyclical) for 48 hours; loss of taste; headache; stuffy nose; pulling on left upper chest; every 6 hours heavy sweating; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Dec2021 08:00 (Batch/Lot number: unknown; Not available/provided to reporter at the time of report completion) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "high uric acid" (unspecified if ongoing); "Sulfadrugs" (unspecified if ongoing). Concomitant medication(s) included: FEBUXOSTAT. Past drug history included: Augmentin - amoxicilline when given with clauvenic acid, reaction(s): "Known allergies: Augmentin", notes: Known allergies: Augmentin-amoxiciline when given with Clauvenic Acid (but amoxiciline alone is ok). Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown, Arm Left), administration date: Mar2021, when the patient was 55 years old, for COVID-19 immunization, reaction(s): "pulling on left upper chest"; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown, Arm Left), administration date: Apr2021, when the patient was 55 years old, for COVID-19 immunization, reaction(s): "pulling on left upper chest". The following information was reported: PYREXIA (non-serious) with onset 21Dec2021 09:00, outcome "recovered" (23Dec2021), described as "high fever (cyclical) for 48 hours"; IMMUNISATION (non-serious), outcome "unknown", described as "dose number = 3"; VACCINATION SITE PAIN (non-serious) with onset 21Dec2021 09:00, outcome "unknown", described as "Sever soreness of at the site of injection"; HYPERHIDROSIS (non-serious) with onset 21Dec2021, outcome "unknown", described as " every 6 hours heavy sweating"; AGEUSIA (non-serious) with onset 21Dec2021 09:00, outcome "unknown", described as "loss of taste"; HEADACHE (non-serious) with onset 21Dec2021 09:00, outcome "unknown", described as "headache"; NASAL CONGESTION (non-serious) with onset 21Dec2021 09:00, outcome "unknown", described as "stuffy nose"; MUSCULOSKELETAL CHEST PAIN (non-serious) with onset 21Dec2021 09:00, outcome "unknown", described as "pulling on left upper chest". Therapeutic measures were not taken as a result of hyperpyrexia, vaccination site pain, hyperhidrosis, ageusia, headache, nasal congestion, musculoskeletal chest pain.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Hospital. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. The patient considered the event as not serious (also reported as serious: No). List of any other medications the patient received within 2 weeks of vaccination: Febuxostat 40 mg one per day. It was reported that pulling on left upper chest (I got this symptom on the first two doses as well, rushed to ER, but no heart problem was found in the ER). Prior to vaccination, was the patient diagnosed with COVID-19?: No. Since the vaccination, has the patient been tested for COVID-19?: No.   The lot number for bnt162b2 was not provided and will be requested during follow up.